T cell and cytokine abnormalities in patients with autoimmune thrombocytopenic purpura

Transfusion and Apheresis Science

Volumn 28, Issue 3, 2003, Pages 237-242

  Semple, John W ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Autoimmune thrombocytopenic purpura; Autoimmunity; Cytokines; HLA; Immunoregulation; Platelets; T cells

Indexed keywords

AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; HELPER CELL; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; LITERATURE; MACROPHAGE; PHAGOCYTOSIS; RETICULOENDOTHELIAL SYSTEM; REVIEW; SPLEEN; THROMBOCYTE;

EID: 0037410054     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(03)00041-7     Document Type: Review

References (37)

1. Semple J.W., Freedman J. Cellular immune mechanisms in chronic autoimmune thrombocytopenic purpura. Autoimmunity. 13:1992;311-319.
2. Semple J.W., Freedman J. Abnormal cellular immune mechanisms associated with autoimmune thrombocytopenia. Transfus. Med. Rev. 9:1995;327-338.
3. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annual Rev. Immunol. 15:1997;821-850.
4. Chambers C.A. The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol. 22:2001;217-223.
5. Elson C.J., Barker R.N. Helper T cells in antibody-mediated, organ-specific autoimmunity. Curr. Opin. Immunol. 12:2000;664-669.
6. Mosmann R.T., Sad D. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
7. Romangnani S. Th1 and Th2 subsets in human diseases. Clin. Immunol. Immunopath. 80:1996;225-235.
8. Paliard X., de Waal Malefyt R., Yssel H. Simultaneous production of Il-2, Il-4 and INF-γ by activated human CD4+ and CD8+ T cell clones. J. Immunol. 141:1988;849-855.
9. Yssel H., de Vries J., de Waal Malefyt R. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J. Immunol. 149:1992;2378-2384.
10. Sinha A.A., Lopez T., McDevitt H.O. Autoimmune diseases: the failure of self-tolerance. Science. 248:1990;1380-1388.
11. Mackay I.R. The "autoimmune diseases" 40th anniversary. Autoimmun. Rev. 1:2002;5-11.
12. Rosmalen J.G.M., van Ewijk W., Leenen P.J.M. T-cell education in autoimmune diabetes: teachers and students. Trends Immunol. 23:2002;40-46.
13. Doyle H.A., Mamula M.J. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol. 2001;22443-22449.
14. Coutinho A., Haas W. In vivo models of dominant T-cell tolerance: where do we stand today? Trends Immunol. 22:2001;350-351.
15. Blanchette V.S., Semple J.W., Freedman J. Intravenous immunoglobulin and Rh immunoglobulin as immunomodulators of autoimmunity to blood elements. Silberstein L.E. Autoimmune disorders of blood. 1996;35-77 American Association of Blood Banks Press, Bethesda.
16. Semple J.W., Freedman J. Enhanced antiplatelet lymphocyte reactivity in patients with autoimmune thrombocytopenia (AITP). Blood. 78:1991;2619-2625.
17. Ware R.R., Howard T.A. Phenotypic and clonal analysis of T lymphocytes in childhood immune thrombocytopenic purpura. Blood. 82:1993;2137-2142.
18. Filion M.C., Bradley A.J.et al. Autoreactive T cells in healthy individuals show tolerance in vitro with characteristics similar to but distinct from clonal anergy. Eur. J. Immunol. 25:1995;3123-3127.
19. Shimomura T., Fujimura K.et al. Oligoclonal accumulation of T cells in peripheral blood from patients with idiopathic thrombocytopenic purpura. Brit. J. Haematol. 95:1996;732-737.
20. Kuwana M., Kaburaki J., Ikeda Y. Autoreactive T cells to platelets GPIIbIIIa in immune thrombocytopenic purpura: a role in production of antiplatelet autoantibody. J. Clin. Invest. 102:1998;1393-1402.
21. Kuwana M., Kaburaki J., Kitasato H.et al. Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood. 98:2001;130-139.
22. Semple J.W., Speck E.R., Kim M., Blanchette V.S., Freedman J. Characterization and fine specificity of platelet-reactive T cell lines from children with chronic autoimmune thrombocytopenic purpura (AITP). Blood. 98(suppl. 1):2001;440a.
23. Semple J.W., Milev Y., Cosgrave D.et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura. Blood. 87:1996;4225-4254.
24. Garcia-Suarez J., Prieto A., Reyes E.et al. Abnormal γIFN and αTNF secretion in purified CD2+ cells from autoimmune thrombocytopenic purpura patients: their implication in the clinical course of the disease. Am. J. Hematol. 49:1995;271-276.
25. Abboud M.R., Laver J., Xu F.et al. Serum levels of GM-CSF are elevated in patients with thrombocytopenia. Brit. J. Haematol. 92:1996;486-488.
26. Lazarus A.H., Ellis J., Semple J.W.et al. Comparison of platelet immunity in patients with SLE and ITP. Transfus. Sci. 22:2000;19-27.
27. Yoshimura C., Nomura S.et al. Plasma-soluble Fas (APO-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura. Eur. J. Haematol. 64:2000;219-224.
28. Shenoy S., Mohanakumar T., Chatila T.et al. Defective apoptosis in lymphocytes and the role of IL-2 in autoimmune hematologic cytopenias. Clin. Immunol. 99:2001;266-275.
29. Mouzaki A., Theodoropoulou M.et al. Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis. Blood. 100:2002;1774-1779.
30. Andersson PO, Olsson B, Carlsson B, et al. Gene expression profiling of T lymphocytes in chronic ITP. Proc Eur Haematol Assoc Annual Meeting, Italy, in press.
31. Crossley A.R., Dickinson A.M.et al. Effects of interferon-alpha therapy on immune parameters in immune thrombocytopenic purpura. Autoimmunity. 24:1996;81-100.
32. Webber N.P., Mascarenhas J.O.et al. Functional properties of lymphocytes in idiopathic thrombocytopenic purpura. Hum. Immunol. 62:2001;1346-1355.
33. Erduran E., Aslan Y., Aliyazicioglu Y.et al. Plasma soluble interleukin-2 receptor levels in patients with idiopathic thrombocytopenic purpura. Am. J. Hematol. 57:1998;119-123.
34. Tan B., Zhao X., Yin C. Detection of IL-2 receptor in patients with idiopathic thrombocytopenic purpura. Hunan Yi Ke Da Xue Xue Bao. 23:1998;191-193.
35. Andersson P.O., Stockelberg D.et al. A transforming growth factor-beta 1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann. Hematol. 79:2000;507-513.
36. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-β Ann. Rev. Immunol. 16:1998;137-161.
37. Karakantza M., Mouzaki A.et al. Th1 and Th2 cytokines in a patient with Evan's syndrome and profound lymphopenia. Brit. J. Haematol. 110:2000;968-970.